EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recombinant Production of The Cyclotide Kalata B1 by Conditional Split Inteins

Abdulkadir Yayci iD, Yen-Hua Huang iD, Peta J Harvey iD, David J Craik iD

ChemBioChem · 2025

DOI: 10.1002/cbic.202400591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Abdulkadir Yayci und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University o…. Hauptthemen laut MEDLINE: Inteins, Cyclotides, Recombinant Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Research Council (ARC), Centre of Excellence for Innovations in Peptide and Protein Science, German Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study describes the design, production, and characterization of a novel conditional intein system for the recombinant production of cyclic peptides. The system is based on two key features: (1) a promiscuous extein recognition site allowing cyclization of virtually any peptide, and (2) a secondary split site within the intein itself enabling triggered splicing at will. Two intein precursors were recombinantly expressed, purified, and then self‐assembled in vitro to cyclize the model peptide kalata B1 (kB1). Cyclized kB1 was successfully purified, refolded, and characterized by mass spectrometry and NMR, demonstrating correct disulfide bond formation and identical structure to synthetic kB1. Importantly, the intein‐derived kB1 retained full biological activity as evidenced by insect cell toxicity assays. This work establishes a versatile and efficient approach for intein‐mediated protein cyclization with potential applications in bioengineering and peptide discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InteinsCyclotidesRecombinant ProteinsAnimalsCyclizationProtein SplicingAmino Acid Sequence

Stichwörter der Autor:innen

CyclizationCyclotideInteinPeptideSiclopps

Substanzen

Cyclotideskalata B1Recombinant Proteins

Autor:innen und Institutionen

  • Institute for Molecular Bioscience, Australian Research Council Centre of Excellence for Innovations in Peptide and Protein Science, The University of Queensland, Brisbane QLD, 4072, Australia.

ORCID-Profile: Abdulkadir Yayci, Yen-Hua Huang, Peta J Harvey, David J Craik

Förderung

  • Australian Research Council (ARC)
  • Centre of Excellence for Innovations in Peptide and Protein Science
  • German Research Foundation
  • National Health and Medical Research Council
  • NHMRC
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Yayci, A., Huang, Y. H., Harvey, P. J., & Craik, D. J. (2025). Recombinant Production of The Cyclotide Kalata B1 by Conditional Split Inteins. ChemBioChem. https://doi.org/10.1002/cbic.202400591

Vancouver

Yayci A, Huang YH, Harvey PJ, Craik DJ. Recombinant Production of The Cyclotide Kalata B1 by Conditional Split Inteins. ChemBioChem. 2025. doi:10.1002/cbic.202400591

BibTeX
@article{Yayci2025,
  author = {Yayci, Abdulkadir and Huang, Yen-Hua and Harvey, Peta J and Craik, David J},
  title = {Recombinant Production of The Cyclotide Kalata B1 by Conditional Split Inteins},
  journal = {ChemBioChem},
  year = {2025},
  doi = {10.1002/cbic.202400591}
}
Kostenlos starten →